Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus

Member of:

  • Neurology


Publication year:
All
51 - 75 out of 256Page size: 25
  1. 2019
  2. Published

    The Multiple Sclerosis Care Unit

    Sørensen, Per Soelberg, Giovannoni, G., Montalban, X., Thalheim, C., Zaratin, P. & Comi, G., Apr 2019, In: Multiple Sclerosis Journal. 25, 5, p. 627-636

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Pulsed immune reconstitution therapy in multiple sclerosis

    Sørensen, Per Soelberg & Sellebjerg, Finn Thorup, Mar 2019, In: Therapeutic Advances in Neurological Disorders. 12, p. 1-16

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy

    Members of Danish Multiple Sclerosis Group, M. O. D. M. S. G., Sellebjerg, Finn Thorup, Magyari, M., Blinkenberg, M., Oturai, A. B., Fredriksen, Jette Lautrup, Jensen, Michael Broksgaard, Tørring, J., Pfleger, C. C. & Weglewski, Arkadiusz, Feb 2019, In: Journal of Neurology. 266, 2, p. 306-315

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

    On behalf of the ABIRISK Consortium, O. B. O. T. A. C., Jan 2019, In: Journal of Neuroimmunology. 326, p. 19-27

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, Finn Thorup, Fredriksen, Jette Lautrup, Góra, M. K., Illes, Z., Kant, M., Mezei, Z., Petersen, T., Rasmussen, P. V., Roshanisefat, H., Hassanpour-Kalam-Roudy, H., Sejbæk, T., Tsakiri, A., Weglewski, Arkadiusz, Sørensen, Per Soelberg & Magyari, M., 2019, In: Neurology. 92, 16, p. e1811-e1820

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    Comi, G., Cook, S., Giovannoni, G., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Galazka, A., Nolting, A., Hicking, C. & Dangond, F., 2019, In: Multiple Sclerosis and Related Disorders. 29, p. 168-174 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

    Stuve, O., Sørensen, Per Soelberg, Leist, T., Giovannoni, G., Hyvert, Y., Damian, D., Dangond, F. & Boschert, U., 2019, In: Therapeutic Advances in Neurological Disorders. 12, p. 1-16

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

    Petersen, E. R., Ammitzbøll, C., Søndergaard, H. B., Oturai, A. B., Sørensen, Per Soelberg, Nilsson, A. C., Börnsen, L., von Essen, Marina Rode & Sellebjerg, Finn Thorup, 2019, In: Journal of Neuroimmunology. 337, 577085.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., Vlachos, I. S., McCabe, C., Pers, T. H., Brandes, A., White, C., Keenan, B., Cimpean, M., Winn, P., Panteliadis, I. P., Robbins, A., Andlauer, T. F. M. & 32 others, Zarzycki, O., Dubois, B., Goris, A., Søndergaard, H. B., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Ullum, H., Thørner, L. W., Saarela, J., Cournu-Rebeix, I., Damotte, V., Fontaine, B., Guillot-Noel, L., Lathrop, M., Vukusic, S., Berthele, A., Pongratz, V., Buck, D., Gasperi, C., Graetz, C., Grummel, V., Hemmer, B., Hoshi, M., Knier, B., Korn, T., Lill, C. M., Luessi, F., Karpe, F., Lage, K., Oturai, A., International Multiple Sclerosis Genetics Consortium, I. M. S. G. C. & ANZgene, IIBDGC, WTCCC2, A. I. W., 2019, In: Science. 365, 6460, eaav7188.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

    Sellebjerg, Finn Thorup, Royen, L., Sørensen, Per Soelberg, Oturai, A. B. & Jensen, P. E. H., 2019, In: Multiple Sclerosis Journal. 25, 11, p. 1444-1451 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

    Petersen, E. R., Søndergaard, H. B., Laursen, J. H., Olsson, A. G., Börnsen, L., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Bang Oturai, A., 2019, In: Multiple Sclerosis Journal. 25, 9, p. 1298-1305 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

    International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, I. C. O. S. C. I. A. I. I. M. S. A. N. O. S. D., 2019, In: The Lancet Neurology. 18, 2, p. 185-197 13 p.

    Research output: Contribution to journal › Review › Research › peer-review

  14. Published

    The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis

    Magyari, M. & Sørensen, Per Soelberg, 2019, In: Current Opinion in Neurology. 32, 3, p. 320-326

    Research output: Contribution to journal › Review › Research › peer-review

  15. 2018
  16. Published

    Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

    Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., Mowry, E. M. & 10 others, Sørensen, Per Soelberg, Tintoré, M., Traboulsee, A. L., Trojano, M., Uitdehaag, B. M. J., Vukusic, S., Waubant, E., Weinshenker, B. G., Reingold, S. C. & Cohen, J. A., 2018, In: Lancet Neurology. 17, 2, p. 162-173

    Research output: Contribution to journal › Review › Research › peer-review

  17. Published

    Disability in progressive MS is associated with T2 lesion changes

    Ammitzbøll, C., Dyrby, T. B., Lyksborg, M., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Garde, E., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2018, In: Multiple Sclerosis and Related Disorders. 20, p. 73-77

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

    Montalban, X., Gold, R., Thompson, A. J., Otero-Romero, S., Amato, M. P., Chandraratna, D., Clanet, M., Comi, G., Derfuss, T., Fazekas, F., Hartung, H. P., Havrdova, E., Hemmer, B., Kappos, L., Liblau, R., Lubetzki, C., Marcus, E., Miller, D. H., Olsson, T., Pilling, S. & 7 others, Selmaj, K., Siva, A., Sørensen, Per Soelberg, Sormani, M. P., Thalheim, C., Wiendl, H. & Zipp, F., 2018, In: Multiple Sclerosis Journal. 24, 2, p. 96-120

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Early versus later treatment start in multiple sclerosis: a register-based cohort study

    the Danish Multiple Sclerosis Group, T. D. M. S. G., 2018, In: European Journal of Neurology. 25, 10, p. 1262-e110

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

    Amato, M. P., Derfuss, T., Hemmer, B., Liblau, R., Montalban, X., Sørensen, Per Soelberg, Miller, D. H. & 2016 ECTRIMS Focused Workshop Group, 2. E. F. W. G., 2018, In: Multiple Sclerosis Journal. 24, 5, p. 590-603

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study

    Comi, G., Cook, S., Rammohan, K., Sørensen, Per Soelberg, Vermersch, P., Adeniji, A. K., Dangond, F. & Giovannoni, G., 2018, In: Therapeutic Advances in Neurological Disorders. 11, p. 1-11

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K., Rieckmann, P., Comi, G., Dangond, F., Adeniji, A. K. & Vermersch, P., 2018, In: Multiple Sclerosis Journal. 24, 12, p. 1594-1604

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Smoking affects the interferon beta treatment response in multiple sclerosis

    Petersen, E. R., Oturai, A. B., Koch-Henriksen, N., Magyari, M., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Søndergaard, H. B., 2018, In: Neurology. 90, 7, p. e593-e600

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study

    Bar-Or, A., Grove, R. A., Austin, D. J., Tolson, J. M., VanMeter, S. A., Lewis, E. W., Derosier, F. J., Lopez, M. C., Kavanagh, S. T., Miller, A. E. & Sørensen, Per Soelberg, 2018, In: Neurology. 90, 20, p. e1805-e1814

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management

    Fernández, O., Delvecchio, M., Edan, G., Fredrikson, S., Giovannoni, G., Hartung, H. P., Havrdova, E., Kappos, L., Pozzilli, C., Sørensen, Per Soelberg, Tackenberg, B., Vermersch, P. & Comi, G., 2018, In: European Journal of Neurology. 25, 5, p. 739-746 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. 2017
  27. Published

    Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality

    Thormann, A., Sørensen, Per Soelberg, Koch-Henriksen, N., Laursen, B. & Magyari, M., 17 Oct 2017, In: Neurology. 89, 16, p. 1668-1675 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  28. Published

    Spinal cord atrophy in anterior-posterior direction reflects impairment in multiple sclerosis

    Lundell, H., Svolgaard, O., Dogonowski, A., Romme Christensen, J., Selleberg, F., Sørensen, Per Soelberg, Blinkenberg, M., Siebner, Hartwig Roman & Garde, E., Oct 2017, In: Acta Neurologica Scandinavica. 136, 4, p. 330-337 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 11025